Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

4.41
Delayed Data
As of Jun 28
 +0.03 / +0.68%
Today’s Change
3.11
Today|||52-Week Range
8.10
-20.83%
Year-to-Date
No recent news for Cytosorbents Corp.

Today’s Trading

Previous close4.38
Today’s open4.40
Day’s range4.32 - 4.43
Volume67,365
Average volume (3 months)70,661
Market cap$111.3M
Dividend yield--
Data as of 06/28/2016

Growth & Valuation

Earnings growth (last year)+74.42%
Earnings growth (this year)-6.82%
Earnings growth (next 5 years)--
Revenue growth (last year)+16.22%
P/E ratioNM
Price/Sales28.93
Price/Book13.55

Competitors

 Today’s
change
Today’s
% change
CDXCChromadex Corp+0.15+4.78%
CDTXCidara Therapeutics ...+0.61+6.25%
IBIOIbio Inc-0.03-4.07%
LFVNLifeVantage Corp+1.30+10.67%
Data as of 06/28/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$4.8M
Annual profit (last year)-$8.1M
Net profit margin-169.71%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Phillip P. Chan
Chief Operating Officer
Vincent Capponi
Corporate headquarters
Monmouth Junction, New Jersey

Forecasts

Partner Offers

Search for Jobs